Clinical Trials in Myeloproliferative Neoplasms (MPN)

 

Trial Name

 

Trial Summary

 

Hyperlink

 

ABBVIE NAVITOCLAX

 

A phase 2 study looking at the addition of Navitoclax, for patients with myelofibrosis who currently take Ruxolitinib.